← All trials
NCT04828564
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 30, 2021
- Primary completion
- Sep 30, 2021
- Completion date
- Dec 31, 2021
- First posted
- Apr 2, 2021
- Last posted
- Apr 2, 2021
- Enrollment
- 100
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- The Scientific and Technological Research Council of TurkeyLead sponsor
- University of AnkaraReponsible party - principal investigator
- Koç UniversityCollaborator
- MonitorCROCollaborator
- Ankara Yildirim Beyazıt UniversityCollaborator
- Umraniye Education and Research HospitalCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.